In the realm of targeted cancer treatment, Carla Leslie is a success story.
Leslie was diagnosed in September of 2010 with Stage 3C breast cancer, a disease that kills 50 to 60 percent of those who have it within five years. She was treated at MD Anderson Cancer Center in Houston with chemotherapy plus Herceptin, a drug that targets a specific genetic mutation in certain kinds of breast cancer. The results were remarkable; Leslie is now in remission.
“It was unbelievable, it was truly unbelievable,” she said. “My experience with the treatment was beyond anything I could have expected.”
